Efficiency of Function-oriented Taping Application in Low Back Pain Patients

April 28, 2025 updated by: Dr. Öğr. Üyesi Muhammed Fatih Kavak, Uskudar University
Purpose of this study is to determine the efficiency of functional tape application to patients with acute or subacute low back pain. 40 patients with acute-subacute low back pain were divided into two groups: control and experimental group. To control group, McKenzie exercises, Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack (HP) and pulsed ultrasound treatments were applied. To experimental group, functional taping were applied in addition of these treatments. Range of Motion (ROM), Visual Analogue Scale (VAS), Tampa Scale of Kinesiophobia (TSK) and The Oswestry Disability Index (ODI) were evaluated preand post-treatment and datas were analyzed with statistical methods. In analysis; p value was accepted p<0,05 for t test and Mann Whitney U test process. In the measurements that compared the improvement of both groups, based on pre- and post-treatment evaluations; improvement in the experimental group was significantly higher in all of these parameters of ROM, VAS, TSK and ODI than in the control group (p<0,05). The use of functional rigid taping in patients with acute and subacute low back pain provided a statistically significant improvement in all measured values of patients and provide better results than the control group. However, there is a need for comparative new studies in order to measure the effectiveness of rigid taping in a more accurate way.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Ümraniye
      • Istanbul, Ümraniye, Turkey
        • Uskudar Üniversity Physiotherapy and Rehabilitation Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being between the ages of 20 and 65
  • Being literate in Turkish
  • Having lower back pain for less than 3 months
  • Informed Consent Form for taping application to have been signed

Exclusion Criteria:

  • Allergic reaction on the skin
  • Hypertension, Type 2 diabetes mellitus (DM) and Presence of accompanying systemic disease other than hypercholesterolemia
  • Not being able to communicate
  • Using corsets and similar supports
  • Having a body mass index > 30
  • Use of antidepressant and myorelexan medication

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: functional taping
McKenzie exercises, Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack (HP) and pulsed ultrasound treatments were applied.To experimental group, functional taping were applied in addition of these treatments.
Other: Experimental group
McKenzie exercises, Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack (HP) and pulsed ultrasound treatments were applied.To experimental group, functional taping were applied in addition of these treatments.
Other: only exercises
McKenzie exercises, Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack (HP) and pulsed ultrasound treatments
Active Comparator: control group with only exercises
McKenzie exercises, Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack (HP) and pulsed ultrasound treatments
Other: only exercises
McKenzie exercises, Transcutaneous Electrical Nerve Stimulation (TENS), Hot Pack (HP) and pulsed ultrasound treatments

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Range of Motion
Time Frame: through study completion, an average of 2 weeks.
The flexion, extension, rotation, and lateral flexion range of motion of the lumbar region will be measured using a goniometer
through study completion, an average of 2 weeks.
Pain intensity
Time Frame: through study completion, an average of 2 weeks.
The Visual Analog Scale (VAS) will evaluate low back pain by asking participants to mark their pain level on a 10 cm scale, where 0 indicates no pain and 10 indicates severe pain, based on their experience over the past week.
through study completion, an average of 2 weeks.
Degree of kinesiophobia
Time Frame: through study completion, an average of 2 weeks
The Tampa Kinesiophobia Scale measures an individual's level of fear related to movement. Participants complete a 17-item questionnaire, indicating their fear and anxiety levels towards specific physical activities or movements. The scale uses a scoring system from 1 to 4 for each item, with a total score of up to 68. Higher scores indicate a higher level of kinesiophobia, while lower scores indicate less fear.
through study completion, an average of 2 weeks
Disability Index
Time Frame: through study completion, an average of 2 weeks
The Oswestry Disability Index (ODI) measures functional limitations in daily activities due to low back pain. The questionnaire consists of 10 sections, each assessing difficulties experienced by the participant due to pain. Participants rate each section from 0 to 5. The total score indicates the level of disability, with higher scores reflecting greater limitations in the individual's quality of life.
through study completion, an average of 2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uskudar University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2017

Primary Completion (Actual)

June 1, 2017

Study Completion (Actual)

June 23, 2017

Study Registration Dates

First Submitted

February 17, 2025

First Submitted That Met QC Criteria

April 28, 2025

First Posted (Actual)

April 30, 2025

Study Record Updates

Last Update Posted (Actual)

April 30, 2025

Last Update Submitted That Met QC Criteria

April 28, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MFKavak-01

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Low Back Pain

Clinical Trials on Experimental group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe